Prestige Consumer Healthcare (PBH): Market Cap to Earnings and Growth Ratio

Corporate company logo of prestigebrands.com (PBH)

Prestige Consumer Healthcare (PBH) maintains a portfolio of recognizable OTC brands and strict FDA oversight that create significant barriers to entry for competitors. A comparison of P/E ratios and growth rates demonstrates valuation dynamics where 1.24 represents the latest level. Secured positions in the hygiene segment guarantee financial stability, while the high counter-cyclical demand for basic medications ensures a reliable cash flow even during GDP declines.

PBH: Prestige Consumer Healthcare PEG Multiple 07/04/2022 - 11/12/2026

Prestige Consumer Healthcare (PBH) - metric breakdowns and financial figures

- current quotes and average value forecast:
Market Price Prestige Brands|PBH - Price Target Chart
- stock exchange capitalization data:
Market Valuation Prestige Consumer Healthcare Inc|PBH - Total Company Value
- balance sheet net asset value indicators:
Accounting Value of a Share Prestige Consumer Healthcare|PBH - Book Capitalization|Market-to-Book Ratio prestigebrands.com|PBH - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Prestige Consumer Healthcare|PBH - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio prestigebrands.com|PBH - Company Aggregate Debts|Debts to Net Assets Prestige Consumer Healthcare Inc|PBH - Company Long-Term Debts|Short-Term Indebtedness Prestige Consumer Healthcare|Immediate Liquidity prestigebrands.com
- earnings and valuation multiples information:
PBH - Net Income|Expected Net Income Prestige Consumer Healthcare|PBH - P/E Multiple|Projected Price to Earnings Prestige Corp|PBH - Price/Earnings to Growth Ratio|Company Value to EBITDA Prestige Consumer Healthcare Inc|PBH - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Prestige Consumer Healthcare|PBH - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months prestigebrands.com|PBH - Net earnings per share growth this year|Earnings growth forecast for next year Prestige Consumer Healthcare
General company analysis:PBH, Prestige Brands
Core merchandise of Prestige Corp

The PEG ratio measures the cost of a single unit of earnings growth, where the value of 1.24 determines the degree of an asset's undervaluation relative to its dynamics. Analyzing the undervalued "rockets" filter via PEG allows for the elimination of market noise, confirming that the resilience of Prestige Consumer Healthcare niche brands and customer loyalty create a genuine foundation for capitalization growth.

Competing companies

CVS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio McKesson Corp. MCK|COR (AmerisourceBergen Corporation) - Market Cap to Earnings and Growth Ratio|CAH - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio HSIC (henryschein.com)|WGRX: PEG Multiple|Price to Earnings Adjusted for Growth Rate 111 Inc. (YI)|Price/Earnings to Growth Ratio China Jo-Jo Drugstores Inc.|Universe Pharma (UPC) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple BDRX (Biodexa Pharmaceuticals)|Company Value to Earnings Growth Ratio HKPD|PEG Multiple BIMI (BIMI Holdings)|Growth-Adjusted Market Cap to Net Income China Jo-Jo Drugstores Inc. (CJJD)|Walgreens - PEG Multiple